The stock of Innoviva Inc (INVA) has seen a -1.13% decrease in the past week, with a -2.95% drop in the past month, and a -9.53% decrease in the past quarter. The volatility ratio for the week is 2.51%, and the volatility levels for the past 30 days are at 2.16% for INVA. The simple moving average for the past 20 days is -0.80% for INVA’s stock, with a 4.74% simple moving average for the past 200 days.
Is It Worth Investing in Innoviva Inc (NASDAQ: INVA) Right Now?
Innoviva Inc (NASDAQ: INVA) has a higher price-to-earnings ratio of 6.78x compared to its average ratio. INVA has 36-month beta value of 0.58. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 2 as “hold,” and 2 as “sell.”
The public float for INVA is 62.43M, and currently, short sellers hold a 20.85% ratio of that float. The average trading volume of INVA on April 04, 2024 was 688.92K shares.
INVA) stock’s latest price update
Innoviva Inc (NASDAQ: INVA) has experienced a rise in its stock price by 0.07 compared to its previous closing price of 14.80. However, the company has seen a fall of -1.13% in its stock price over the last five trading days. InvestorPlace reported 2024-01-10 that The great advances and improvements in the treatment of diseases and the effectiveness of these medicines are undoubtedly due to technological progress and how biotech companies take advantage of it for their growth and development. Without the work of these companies, we would still be using very old and ineffective medicines.
Analysts’ Opinion of INVA
Many brokerage firms have already submitted their reports for INVA stocks, with Goldman repeating the rating for INVA by listing it as a “Neutral.” The predicted price for INVA in the upcoming period, according to Goldman is $16 based on the research report published on July 20, 2022 of the previous year 2022.
Deutsche Bank, on the other hand, stated in their research note that they expect to see INVA reach a price target of $13. The rating they have provided for INVA stocks is “Hold” according to the report published on November 20th, 2017.
INVA Trading at -4.42% from the 50-Day Moving Average
After a stumble in the market that brought INVA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -12.18% of loss for the given period.
Volatility was left at 2.16%, however, over the last 30 days, the volatility rate increased by 2.51%, as shares sank -0.47% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.69% lower at present.
During the last 5 trading sessions, INVA fell by -1.13%, which changed the moving average for the period of 200-days by +12.45% in comparison to the 20-day moving average, which settled at $14.93. In addition, Innoviva Inc saw -7.67% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at INVA starting from Zhen Marianne, who sale 10,994 shares at the price of $13.99 back on Nov 15 ’23. After this action, Zhen Marianne now owns 40,158 shares of Innoviva Inc, valued at $153,810 using the latest closing price.
DENNER ALEXANDER J, the 10% Owner of Innoviva Inc, purchase 8,000 shares at $13.05 during a trade that took place back on Jun 06 ’23, which means that DENNER ALEXANDER J is holding 7,215,000 shares at $104,384 based on the most recent closing price.
Stock Fundamentals for INVA
Current profitability levels for the company are sitting at:
- 0.59 for the present operating margin
- 0.83 for the gross margin
The net margin for Innoviva Inc stands at 0.57. The total capital return value is set at 0.15. Equity return is now at value 28.97, with 14.52 for asset returns.
Based on Innoviva Inc (INVA), the company’s capital structure generated 0.4 points at debt to capital in total, while cash flow to debt ratio is standing at 0.32. The debt to equity ratio resting at 0.66. The interest coverage ratio of the stock is 9.7.
Currently, EBITDA for the company is 149.59 million with net debt to EBITDA at 1.52. When we switch over and look at the enterprise to sales, we see a ratio of 3.8. The receivables turnover for the company is 3.73for trailing twelve months and the total asset turnover is 0.25. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.03.
Conclusion
To put it simply, Innoviva Inc (INVA) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
